智通财经APP讯，华润医药(03320)发布公告，截至2024年12月31日止年度，江中药业实现营业总收入44.35亿元，同比减少2.59%;上市公司股东应占净利润7.85亿元，同比增长9.22%;每股基本盈利1.25元。
报告期内，江中药业坚持“十四五”战略引领，围绕“做强OTC、发展大健康、布局处方药”三大业务布局，增强核心功能、提高核心竞争力。业务方面，江中药业加强OTC产品梯队建设，推动区域市场均衡发展;优化健康消费品业务模式，通过组织重塑提升效能;探索处方药业务发展路径，提升业务合规运营能力。同时，江中药业聚焦制约高质量发展的瓶颈问题，加快主业聚焦、科技创新、组织变革等各项工作，推进江中药业高质量发展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.